Product failure continued

Avoiding product failures can depend, in part, on the ability to predict the performance of plastic materials and their shapes. With available time, the usual approach of product prototype and/or field-testing provides useful and reliable performance data when conducted properly. As an example designers continue to develop sophisticated computer methods for calculating stresses in complex structures. 

The development of commercial continuous processes involves the consideration of many factors associated with process design and product quality. Most of the factors discussed in this paper will be important. Other, equally significant parameters, may be important for specific polymer products. Failure to deal with any of these problems may mean failure to develop an economical process. 

At about the same time, the first information was received about product failure after continuous and exclusive use. The investigation of the pathogen populations of such fields yielded highly resistant strains (28, 29, 40), whereas so far no field resistance has been reported for cymoxanil or fosetyl. Thus, in contrast to the favorable results of a broad range of model studies, resistance had appeared very fast under field conditions. The lesson to be learned from this experience is that results of model studies have to be used with caution. Model studies must include the use of chemical mutagens and highly active, systemic fungicides should be used as if a risk of resistance exists until their mode of action is known. 

A 36-year-old man with acute promyelocytic leukemia was given tretinoin 45 mg/m /day, daunorubi-cin, and cytarabine. A week later his platelet count fell to 10 X 10 /1, and the next day he developed dyspnea, hemoptysis, and fever. A chest X-ray showed diffuse bilateral patchy pulmonary infiltrates. Tretinoin was withdrawn, but despite high doses of glucocorticoids and blood products, hemoptysis and respiratory failure continued for 6 weeks, when he improved. 

Because of many variations in conditions such as cold products versus hot products, weather and wind conditions, various leak geometries, instantaneous releases, massive tank failures, continuous versus intermittent releases, and pipeline leaks versus raUear punetures, there is no universal model to make accurate quantitative predictions of dispersion of ammonia (Pederson and Selig, 1989 Kaiser and Walker, 1978). All models have described the behavior of ammonia on sudden release from pressurized tank as follows ... 

CLASS 2 Dedicated Service Electronic Prodncts Class 2 includes products where continued performance and extended life is required, and for which uninterrupted service is desired but not critical. Typically the end-use environment would not cause failures. CLASS 3 High-Perforniance Electronic Prodncts These include products where continued high performance or performance-on-demand is critical, equipment downtime cannot be tolerated, end-use environment may be uncommonly harsh, and the equipment must function when required. Examples include life support or other critical systems. 

If we use the semi-formal notation to describe requirements, it is useful to also use this for the same basis of the model description. Because ISO 26262 requires a verification after each step, systematic failure could be avoided and the consistency of the work steps and therefore also the work results would be supported. Since the model is also used as test reference according to ISO 26262, the model matures alongside the development process, if the product model continuously validated versus the increasing maturity of the development samples or prototypes. A model is often based on logical elements or function groups. They describe the structure, functional correlations of the elements or their technical behavior accordingly. Therefore, the architecture, the safety analysis and the model should widely have a common basis or refereeing to the safety relevant characteristics at least, they should be consistent. 

Continuous processes have lower labor costs but have higher failure risk. Batch processes can be started back up in a shorter period of time than can a complex continuous process. Batch processes are easier to take through the regulatory process than are continuous processes. Thus batch processes are often chosen for mammalian ceU culture systems, even though continuous processes can offer significant cost advantages. CeU culture costs constitute only a smaU (10—30%) fraction of the overaU cost of making a product. 

Failure modes analysis Statistical process control Measurement systems analysis Employee motivation On-the-job training Efficiency will increase through common application of requirements for Continuous improvement in cost Continuous improvement in productivity Employee motivation On-the-job training... 

A potential cause of nonconforming product is a situation either where a deterioration exists which will result in nonconformity if allowed to continue or the conditions are such that a failure is possible even though there is no evidence that occurrence could be imminent. 

---